PHARMACEUTICALS

Morepen in talks to sell OTC business

September 23, 2016 | Ranjani Raghavan

Morepen Laboratories is in advanced discussions to sell its over the counter (OTC) business to Piramal Enterprises. 

The firm has hired consulting firm Deloitte to find buyers for its OTC business, according to separate media reports. 

Exclusive: Stemade Biotech moves court against drugmaker Generic Partners

September 12, 2016 | Maulik Vyas

Stemade Biotech Pvt. Ltd, a boutique business advisory firm, has dragged Australian pharmaceutical company Generic Partners Pty Ltd to court to settle a dispute with the former client.

Actis elicits interest from investors for stake in Symbiotec Pharmalab

September 12, 2016 | Ranjani Raghavan

Private equity firm Actis Capital, which invested in Symbiotec Pharmalab in October 2013, has received interest from investors for its stake in the Indore-based drugmaker, a person close to the development told VCCircle.

Exclusive: Drugmaker Akums hires banker for potential majority stake sale

September 08, 2016 | Ranjani Raghavan

Contract drug manufacturer Akums Drugs & Pharmaceuticals Ltd has hired a banker for a stake sale, three people familiar with the transaction told VCCircle, exactly a year after one of its units raised funding from venture capital firm Sequoia Capital.

Exclusive: Kotak Private Equity scores a multi-bagger exit

September 06, 2016 | Ranjani Raghavan

Kotak Private Equity, the alternative investment arm of the country’s fourth biggest private lender Kotak Mahindra Bank, has struck an exit from its healthcare-focused fund in what translates into its best known returns in rupee terms.

Exclusive: Amanta Healthcare hires banker for fresh funding

September 02, 2016 | Joseph Rai

Amanta Healthcare, formerly known as Marck Biosciences, has engaged an investment banker for its next round of funding that will involve fresh capital infusion and exit of its existing investor, two people privy to the development told VCCircle.

Exclusive: Baxter scouting for buyers for India intravenous business

September 01, 2016 | Ranjani Raghavan

US-based healthcare firm Baxter International, which lost out to Chinese conglomerate Fosun International in its bid for Gland Pharma, is in talks to sell a part of its India portfolio, three persons familiar with the development told VCCircle. 

Mitra Biotech raises $27.4 mn from Sequoia, Sands Capital, others

August 29, 2016 | Joseph Rai

Mitra Biotech Pvt. Ltd, which focuses on personalised cancer care and rational drug development, has raised $27.4 million in a Series B round of funding co-led by Sequoia India and Washington-based Sands Capital Ventures, it said in a statement.

Aurobindo, Intas bid for Teva’s products in Europe

August 29, 2016 | Ranjani Raghavan

Indian drugmakers Aurobindo Pharma and Intas Pharmaceuticals have submitted binding bids to acquire products from Israel’s Teva Pharmaceutical Industries in the UK, Iceland and

Taparia family buys majority stake in Guardian Lifecare

August 26, 2016 | Joseph Rai

Taparia family, who sold contraceptive maker Famy Care to Mylan for $800 million last year, has acquired a majority stake in pharmacy chain Guardian Lifecare Pvt Ltd that was mired in a legal dispute with its private equity investor Samara Capital.

Pages

Advertisement

Upcoming Events